Malawi and Tanzania have created programs to provide sexual and reproductive health services and HIV interventions. But men who have sex with men say it’s still difficult to access care.
Thomas Aagaard Rasmussen, The Peter Doherty Institute for Infection and Immunity and Sharon Lewin, The Peter Doherty Institute for Infection and Immunity
Ebola’s clever trick – to lie dormant inside a cell or to hide in a particular organ – is not unfamiliar. Lots of viruses do it. HIV is the master of such a trick.
Sasha Petrova, The Conversation and Nicola McCaskill, The Conversation
Researchers have found a promising way of kicking the AIDS virus out of its hiding place in infected cells, potentially removing the main obstacle to curing HIV.
Despite health promotion campaigns and a concerted effort to make antiretroviral therapy more accessible, the number of new HIV cases in Australia has remained stable over the last three years.
The latest instalment of Australia’s annual report card on HIV, hepatitis and sexually transmissible infections has been released this morning. Here’s what experts make of the results.
HIV therapy that enables patients with the virus to live a healthy life is a great success for modern medicine. But what are the challenges to coming up with a complete cure?
New York’s achievements have provided a beacon of hope as well as a road map that has been successfully tailored to the needs of resource-poor settings throughout the world.
Erica Penfold, South African Institute of International Affairs
Medicine shortages in southern Africa, particularly of anti-retrovirals for HIV patients, require urgent attention. A regional approach to distribution has been tried in South America and could work for the region.
Viruses cause all kinds of infections from relatively mild cases of the flu to deadly outbreaks of Ebola. Clearly, not all viruses are equal and one of these differences is when you can infect others.
Indonesia’s war on drugs aims to protect the country’s young generation from an alleged “national drug emergency.” But the government’s coercive approach is harming the people it wishes to protect.
A recent survey of people living with HIV in the United Kingdom found that over half would participate in a clinical study to develop a cure for HIV despite this posing a risk to their health.
Director, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital and Consultant Physician, Department of Infectious Diseases, Alfred Hospital and Monash University, The Peter Doherty Institute for Infection and Immunity
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand